Central Nervous System Pharmacology Practice Questions

Q: Which of the following acetylcholinesterase inhibitors is most commonly prescribed as first-line therapy for mild to moderate Alzheimer's disease due to its once-daily dosing and favorable side effect profile?

Donepezil. ***Donepezil*** - It is frequently chosen as a **first-line agent** for mild to moderate Alzheimer's disease due to its **favorable side effect profile** and **once-daily dosing** [1]. - Its long half-life allows for administration once a day, which can improve **patient adherence** to therapy [1]. *Galantamine* - This acetylcholinesterase inhibitor typically requires **twice-daily dosing**, which is less convenient than donepezil's once-daily regimen [2]. - While effective, it does not hold the same **first-line preference** as donepezil due to its more frequent administration [2]. *Rivastigmine* - Rivastigmine is available in oral and transdermal patch formulations, but its oral form often requires **twice-daily dosing** or more [2]. - Its side effect profile can be more pronounced, particularly **gastrointestinal side effects**, compared to donepezil [2]. *All of the options* - While all listed options are acetylcholinesterase inhibitors used in Alzheimer's disease, **Donepezil** stands out as the most common first-line choice due to its once-daily dosing and well-tolerated profile [1], [2]. - The other options have different dosing schedules or side effect profiles that make them less universally preferred as initial therapy [2].

Q: A 28-year-old woman with a history of seizures is prescribed a classic anticonvulsant that primarily works by inhibiting voltage-gated sodium channels. Which drug is most likely being prescribed?

Phenytoin. ***Phenytoin*** - **Phenytoin** is the **classic prototype anticonvulsant** [1] that primarily works by **blocking voltage-gated sodium channels**, thus stabilizing the neuronal membrane and preventing repetitive firing [2]. - It is effective in treating various seizure types, including **focal** and **generalized tonic-clonic seizures** [1]. - As the traditional first-line agent in this class, it is the most likely answer when referring to a "classic" sodium channel blocker [1]. *Carbamazepine* - While **carbamazepine** also works by **blocking voltage-gated sodium channels** [2], it is structurally related to tricyclic antidepressants and came after phenytoin. - It's often used for **focal seizures** and **trigeminal neuralgia**. - Considered an important alternative but not the "classic" prototype [1]. *Valproate* - **Valproate** has **multiple mechanisms of action**, including inhibiting **GABA transaminase** (increasing GABA levels), blocking **sodium channels**, and modulating **T-type calcium channels** [2]. - Its broad spectrum is useful for both **focal** and **generalized seizures**, including absence seizures. - Not primarily classified as a sodium channel blocker due to its multiple mechanisms. *Lamotrigine* - **Lamotrigine** is a **newer anticonvulsant** [1] that inhibits presynaptic **voltage-gated sodium channels**, reducing the release of excitatory neurotransmitters like glutamate [2]. - It is effective against various seizure types, including **focal**, **generalized tonic-clonic**, and seizures associated with **Lennox-Gastaut syndrome**. - Developed later as a second-generation antiepileptic drug [1].

Q: What is the first-line treatment for a patient presenting with an acute dystonic reaction?

Anticholinergics. ***Anticholinergics*** - **Anticholinergic medications**, such as **benztropine** or **diphenhydramine**, are the **first-line treatment** for acute dystonic reactions. - They work by **blocking muscarinic acetylcholine receptors**, thereby re-establishing the balance between dopamine and acetylcholine in the basal ganglia, which is disrupted in dystonia. *Benzodiazepines* - While benzodiazepines can provide some symptomatic relief by reducing muscle spasms and anxiety, they are **not the first-line treatment** for the underlying neurological cause of acute dystonia. - They primarily act on **GABA receptors**, promoting muscle relaxation, but do not directly address the dopamine-acetylcholine imbalance. *Beta-blockers* - **Beta-blockers** are primarily used to treat conditions like **hypertension**, **anxiety**, or **essential tremor**, and are **not effective** for acute dystonic reactions. - They work by blocking beta-adrenergic receptors and have no direct role in the pathophysiology of dystonia. *Dopamine agonists* - **Dopamine agonists** are typically used to **increase dopamine activity**, as seen in conditions like **Parkinson's disease**. - Acute dystonic reactions are often caused by **dopamine receptor blockade** (e.g., by antipsychotics), so increasing dopamine agonism would generally be **contraindicated** or ineffective.

Q: A patient with Parkinson's disease is given a dopamine agonist to manage motor symptoms by directly stimulating dopamine receptors. Which drug corresponds to this description?

Pramipexole. ***Pramipexole*** - **Pramipexole** is a commonly used **non-ergot dopamine agonist** that **directly stimulates dopamine D2 and D3 receptors** in the brain. - It is effective in managing motor symptoms of **Parkinson's disease** by mimicking the effects of dopamine, particularly in early-stage disease or as an adjunct to levodopa. - Unlike levodopa, it does not require enzymatic conversion and directly activates dopamine receptors. *Levodopa* - **Levodopa** is a **dopamine precursor** that is converted into dopamine in the brain via aromatic L-amino acid decarboxylase (AADC). - It works by **replenishing deficient dopamine levels** rather than directly stimulating dopamine receptors. - It is the most effective symptomatic treatment for Parkinson's disease but is **not a dopamine agonist**. *Selegiline* - **Selegiline** is a **selective monoamine oxidase-B (MAO-B) inhibitor** that prevents the breakdown of dopamine in the brain. - It **increases dopamine availability** by blocking its metabolism but does not directly stimulate dopamine receptors. - It is used as an adjunct therapy to enhance the effects of endogenous or exogenous dopamine. *Entacapone* - **Entacapone** is a **catechol-O-methyltransferase (COMT) inhibitor** that prevents the peripheral breakdown of levodopa. - This action **prolongs the half-life of levodopa**, allowing more to cross the blood-brain barrier, but it does not directly stimulate dopamine receptors. - It is always used in combination with levodopa/carbidopa to enhance levodopa's effectiveness.

Q: A patient with epilepsy is given a drug that enhances GABA activity to prevent seizure activity. Which drug is appropriate?

Valproic acid. ***Valproic acid*** - **Valproic acid** primarily enhances **GABAergic activity** by inhibiting GABA transaminase, increasing GABA synthesis, and reducing GABA reuptake, which collectively help to stabilize neuronal activity and prevent seizures. - It is a **broad-spectrum anticonvulsant** effective against various seizure types, including generalized tonic-clonic, absence, and myoclonic seizures. *Phenytoin* - **Phenytoin** works by **blocking voltage-gated sodium channels**, thereby stabilizing neuronal membranes and preventing repetitive firing of action potentials. - It is effective for **focal (partial) seizures** and generalized tonic-clonic seizures, but its primary mechanism is not direct GABA potentiation. *Gabapentin* - **Gabapentin** modulates the **voltage-gated calcium channels** (specifically the α₂δ subunit), reducing the release of excitatory neurotransmitters. - While it has broad-spectrum effects that can reduce seizure activity, its direct mechanism of action is not primarily through enhancing GABA activity. *Lamotrigine* - **Lamotrigine** stabilizes neuronal membranes by **blocking voltage-gated sodium channels** and, to a lesser extent, inhibiting voltage-gated calcium channels. - It also reduces the release of excitatory neurotransmitters like glutamate, but it does not directly enhance GABAergic transmission.

Q: Ketamine acts on which of the following?

NMDA receptor. ***NMDA receptor*** - **Ketamine** primarily acts as an **N-methyl-D-aspartate (NMDA) receptor antagonist**, blocking the effects of **glutamate**. - This action leads to its **dissociative anesthetic** effects, including analgesia, amnesia, and a cataleptic state. *Glycine receptor* - The **glycine receptor** is an inhibitory ionotropic receptor, primarily found in the **spinal cord** and brainstem. - Its activation leads to **hyperpolarization** and a decrease in neuronal excitability, a mechanism distinct from ketamine's action. *GABAa receptor* - The **GABAa receptor** is the primary inhibitory neurotransmitter receptor in the brain, and drugs like **benzodiazepines** and **barbiturates** act on it to produce sedation. - While ketamine has some indirect GABAergic effects at high doses, its primary mechanism of action is not through direct binding to GABAa receptors. *Ach receptor* - The **acetylcholine (Ach) receptor** is involved in various functions, including muscle contraction (nicotinic receptors) and parasympathetic responses (muscarinic receptors). - Drugs like **atropine** and **neostigmine** target these receptors, which are not the primary site of action for **ketamine**.

Q: Which antiepileptic drug is used for neuropathic pain and works by inhibiting voltage-gated calcium channels?

Gabapentin. ***Gabapentin*** - **Gabapentin** is a commonly used antiepileptic drug that primarily acts by binding to the **alpha-2-delta subunit of voltage-gated calcium channels**, reducing calcium influx and subsequent neurotransmitter release. - This mechanism is particularly effective in treating **neuropathic pain**, such as diabetic neuropathy and postherpetic neuralgia. *Carbamazepine* - **Carbamazepine** works primarily by blocking **voltage-gated sodium channels**, thereby stabilizing neuronal membranes and inhibiting repetitive neuronal firing. - While effective for certain types of pain, like **trigeminal neuralgia**, its primary mechanism and widespread use for general neuropathic pain differ from gabapentin. *Levetiracetam* - **Levetiracetam's** precise mechanism of action is not fully understood, but it is thought to involve binding to the **synaptic vesicle protein 2A (SV2A)**, modulating neurotransmitter release. - It is primarily used as an antiepileptic for various seizure types and is generally **not a first-line treatment for neuropathic pain**. *Lamotrigine* - **Lamotrigine** works by blocking **voltage-gated sodium channels** and, to a lesser extent, **calcium channels**, thereby stabilizing neuronal membranes and inhibiting excitatory neurotransmitter release. - While it has some efficacy in neuropathic pain, its primary mechanism and therapeutic profile are distinct from gabapentin's selective action on voltage-gated calcium channels.

Q: What are the possible CNS effects of local anesthetic agents?

All of the options. ***All of the options*** - **All three listed effects are genuine CNS manifestations** of local anesthetic systemic toxicity (LAST). - Local anesthetics produce a **biphasic CNS effect**: initial excitatory symptoms (perioral numbness, seizures) followed by depressive symptoms at higher concentrations. - Since the question asks for "**possible** CNS effects" (not the most severe or primary effect), all listed options are medically accurate answers. **CNS Effects of Local Anesthetics:** **Early/Excitatory Phase:** - *Perioral numbness* - Often the first CNS sign, indicating rising plasma levels; numbness and tingling around the mouth and tongue - *Convulsions/Seizures* - Result from blockade of inhibitory neurons, causing uninhibited excitatory activity; a serious manifestation requiring immediate treatment **Late/Depressive Phase:** - *Depression* - Occurs at very high toxic concentrations; includes CNS depression, loss of consciousness, respiratory depression, and potentially coma - This follows the excitatory phase as local anesthetics depress all neuronal activity at extremely high doses *Convulsions alone* - While convulsions are a serious and characteristic CNS effect, they represent only one possible manifestation, not all possible effects. *Perioral numbness alone* - This is an early warning sign of LAST but not the only CNS effect possible. *Depression alone* - This is a late-stage effect but not the only CNS manifestation possible.

Q: What is the drug of choice for smoking cessation?

Varenicline. ***Varenicline*** - **Varenicline** is a **partial agonist** at the **α4β2 nicotinic acetylcholine receptor**, reducing cravings and withdrawal symptoms while blocking the pleasurable effects of nicotine [1]. - It is often considered the **first-line pharmacological treatment** for smoking cessation due to its superior efficacy compared to other monotherapies. *Acamprosate* - **Acamprosate** is primarily used to maintain **abstinence from alcohol** in patients with alcohol dependence. - Its mechanism involves modulating **glutamatergic activity**, primarily at **NMDA receptors**, which is not directly relevant to nicotine addiction. *Thalidomide* - **Thalidomide** is an **immunomodulatory** and **anti-angiogenic drug** used in conditions like **multiple myeloma** and **leprosy**. - It has no role or approved indication for **smoking cessation**. *Tryptophan* - **Tryptophan** is an **amino acid** that serves as a precursor to **serotonin**, a neurotransmitter involved in mood regulation. - While sometimes explored for mood or sleep issues, it is **not indicated** or effective as a primary treatment for **smoking cessation**.

Q: Which of the following drugs is useful in the prophylaxis of migraine?

Propranolol. ***Propranolol*** - **Propranolol** is a **beta-blocker** commonly used for **migraine prophylaxis** by reducing the frequency and severity of attacks. - It works by modulating **serotonergic pathways** and reducing the body's **fight-or-flight response**, which can be a trigger for migraines. *Sumatriptan* - **Sumatriptan** is a **serotonin (5-HT1B/1D) receptor agonist** used for the **acute treatment** of migraine attacks, not for prophylaxis. - It works by causing **vasoconstriction** of cranial blood vessels and inhibiting the release of **pro-inflammatory neuropeptides**. *Domperidone* - **Domperidone** is a **dopamine antagonist** used as an **antiemetic** to relieve nausea and vomiting, which can be associated with migraine attacks. - It does not have a role in the **prophylactic treatment** of migraine itself. *Ergotamine* - **Ergotamine** is an **ergot alkaloid** used for the **acute treatment** of moderate to severe migraines. - Due to its potential for **vasoconstriction** and **drug-induced headache** (medication overuse headache), it is not recommended for routine prophylaxis.

Question 1

Which of the following acetylcholinesterase inhibitors is most commonly prescribed as first-line therapy for mild to moderate Alzheimer's disease due to its once-daily dosing and favorable side effect profile?

Accepted Answer

Donepezil

Answer

Galantamine

Answer

Rivastigmine

Answer

All of the options

Question 2

A 28-year-old woman with a history of seizures is prescribed a classic anticonvulsant that primarily works by inhibiting voltage-gated sodium channels. Which drug is most likely being prescribed?

Accepted Answer

Phenytoin

Answer

Valproate

Answer

Carbamazepine

Answer

Lamotrigine

Question 3

What is the first-line treatment for a patient presenting with an acute dystonic reaction?

Accepted Answer

Anticholinergics

Answer

Benzodiazepines

Answer

Beta-blockers

Answer

Dopamine agonists

Question 4

A patient with Parkinson's disease is given a dopamine agonist to manage motor symptoms by directly stimulating dopamine receptors. Which drug corresponds to this description?

Accepted Answer

Pramipexole

Answer

Levodopa

Answer

Selegiline

Answer

Entacapone

Question 5

A patient with epilepsy is given a drug that enhances GABA activity to prevent seizure activity. Which drug is appropriate?

Accepted Answer

Valproic acid

Answer

Phenytoin

Answer

Gabapentin

Answer

Lamotrigine

Question 6

Ketamine acts on which of the following?

Accepted Answer

NMDA receptor

Answer

Glycine receptor

Answer

GABAa receptor

Answer

Ach receptor

Question 7

Which antiepileptic drug is used for neuropathic pain and works by inhibiting voltage-gated calcium channels?

Accepted Answer

Gabapentin

Answer

Carbamazepine

Answer

Levetiracetam

Answer

Lamotrigine

Question 8

What are the possible CNS effects of local anesthetic agents?

Accepted Answer

All of the options

Answer

Convulsions

Answer

Perioral numbness

Answer

Depression

Question 9

What is the drug of choice for smoking cessation?

Accepted Answer

Varenicline

Answer

Acamprosate

Answer

Thalidomide

Answer

Tryptophan

Question 10

Which of the following drugs is useful in the prophylaxis of migraine?

Accepted Answer

Propranolol

Answer

Sumatriptan

Answer

Domperidone

Answer

Ergotamine

Central Nervous System Pharmacology — MCQs

Central Nervous System Pharmacology — MCQs

On this page

Practice by Chapter

Want unlimited practice?